116209-31-5

Basic information

• Product Name: Benzoic acid, 2-chloro-4-mercapto-
• CAS NO: 116209-31-5
• Molecular Formula: C7H5ClO2S
• Molecular Weight: 188.635
• Mol File: 116209-31-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-chloro-4-mercapto-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-chloro-4-mercapto-(116209-31-5)
• EPA Substance Registry System: Benzoic acid, 2-chloro-4-mercapto-(116209-31-5)

Safety Data

• Hazardous Substances Data: 116209-31-5(Hazardous Substances Data)

Upstream product

• 46004-37-9 methyl 4-amino-2-chlorobenzoate 
• 13324-11-3 methyl 2-chloro-4-nitrobenzoate 
• 1190947-66-0 methyl 2-chloro-4-(ethoxycarbonothioylthio)benzoate 
• 2457-76-3 4-amino-2-chlorobenzoic acid 
• 99-60-5 2-chloro-4-nitrobenzoic acid 

Downstream Products

• 81542-91-8 2,2'-dichloro-4,4'-dithiobis(benzoic acid) 
• 830335-81-4 C₁₈H₁₆Cl₂O₄S₂ 
• 879088-84-3 methyl 2-chloro-4-mercaptobenzoate 

Relevant articles and documents

PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE

Piperidine compounds of the Formular: (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R 1, R 2, R 3, L, R 4, L 1, Q and R 5 are as defined herein. The compounds and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

Pyridyl inhibitors of hedgehog signalling

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.